1,788 enforcement actions from 16 federal and state jurisdictions. Every event traced back to its official government source.
1,788
Total Actions
16
Jurisdictions
$51.8B+
Total Fines Tracked
Connecticut joined 39 other states and the federal government in a $384 million False Claims Act settlement with Abbott Laboratories over allegations that the company failed to manufacture powder infant formula and nutritional therapy products in compliance with federal and state requirements at its Sturgis, Michigan, and Casa Grande, Arizona facilities. Abbott allegedly manufactured formula in conditions that risked microorganism contamination and failed to disclose contamination test results to the FDA during 2019 and 2022 inspections. The settlement resolves claims that Abbott caused false claims to be submitted to the WIC program and state Medicaid programs between January 1, 2018, and December 31, 2022.
$384.2M
Abbott Laboratories agreed to pay more than $384 million — including $977,558 to Oregon — to resolve allegations that it sold powder infant formula and nutritional therapy products made in unsafe manufacturing conditions to Medicaid and food assistance programs such as WIC between January 2018 and December 2022. Investigators found Abbott failed to maintain manufacturing equipment and control water at its Sturgis, Michigan, and Casa Grande, Arizona, facilities, and withheld test results showing contamination during FDA inspections in 2019 and 2022. The settlement was negotiated by the National Association of Medicaid Fraud Control Units on behalf of the federal government and 39 states.
$384.2M
Minnesota Attorney General Keith Ellison announced the first round of restitution, issuing 8 refund checks totaling $38,634 to consumers harmed by Omega Dental Care, a defunct Eden Prairie dental clinic owned and operated by Anne Soberay. The refunds, paid from the state's Consumer Protection Restitution Account (CPRA), compensate consumers who paid out of pocket for dental services that were never provided. The refunds follow an earlier settlement between the AG's office and Omega Dental Care and Soberay. Note: this is a consumer protection (non-delivery of services) action, not a privacy enforcement action; no privacy violation types from the taxonomy apply.
New Jersey and a coalition of states and territories obtained preliminary approval for a plan to distribute funds from settlements with generic drug manufacturers accused of conspiring to raise drug prices. The settlements total approximately $96.5 million, and eligible consumers may submit claims for compensation.
$96.5M
The Minnesota Attorney General entered into a 10-year oversight agreement with Sanford Health and North Memorial Health to allow their merger to proceed, conditioned on commitments to invest $600 million in Minnesota hospitals, maintain core services including the Level 1 trauma center at Robbinsdale Hospital, honor collective-bargaining agreements, and maintain charity care and government program participation. The agreement also requires quarterly meetings and annual reporting to the Attorney General for 10 years.
Attorney General Weiser joined a coalition of attorneys general in suing to block new unlawful conditions on Title X funding imposed by HHS, which would penalize states and providers that refuse to abandon nondiscrimination initiatives or conform to the administration's ideological vision of family planning. The lawsuit argues the conditions conflict with federal law, violate the Administrative Procedure Act, and are unconstitutionally vague.
New York Attorney General Letitia James secured $400,000 from Thirty Madison, Inc., an online medication provider, for misleading consumers about auto-renewing subscriptions and making cancellation difficult. The company failed to clearly disclose subscription terms and non-refundable fees, and required multiple steps to cancel. The settlement requires payment, refunds to eligible subscribers, and changes to subscription practices.
$400K
Attorney General William Tong sent a letter to the Connecticut Insurance Department urging rejection of double-digit rate increases sought by Anthem, ConnectiCare, and UnitedHealthcare for individual and small group health insurance plans covering about 220,000 people. The letter argues the rates exceed inflationary measures and criticizes the carriers for failing to control costs and for poor claims system management, particularly ConnectiCare's transition to Molina Healthcare.
Minnesota Attorney General Keith Ellison reached a settlement with Stevens Community Medical Center (SCMC) over allegations that SCMC improperly calculated discounts required for uninsured patients with household incomes under $125,000, violating the Minnesota Hospital Agreement and state law. As a result, some uninsured patients were billed up to 20.5% more than allowed. SCMC must provide up to $1,412,776.25 in refunds or medical-debt reductions to potentially eligible patients.
$1.4M
Texas Attorney General Ken Paxton launched an investigation into the American Academy of Pediatrics (AAP) over concerns that the organization may be promoting and recommending childhood vaccines for financial gain. The AAP has been issued a Civil Investigative Demand to determine the basis of its vaccine recommendations and whether they are influenced by financial incentives from pharmaceutical donors.
Attorney General Jennifer Davenport joined a coalition of 43 states and territories in announcing a $400 million settlement in principle with Sandoz Inc. to resolve allegations of widespread price-fixing and anticompetitive conduct in the generic drug market. Sandoz will pay approximately $469 million total including prior settlements, and has agreed to internal reforms to ensure fair competition.
$400.0M
Minnesota Attorney General Keith Ellison joined a coalition of 43 states and territories in announcing a $400 million settlement in principle with Sandoz Inc. to resolve allegations that the generic drug manufacturer engaged in conspiracies to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade for numerous generic prescription drugs. Sandoz will pay approximately $469 million total including prior settlements, and has agreed to injunctive terms and internal reforms.
$400.0M
Attorney General Phil Weiser joined a coalition of 43 states and territories announcing a $400 million settlement in principle with Sandoz Inc. to resolve allegations that the generic drug manufacturer engaged in conspiracies to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade. Sandoz will pay approximately $469 million including previous settlements and agreed to meaningful reforms to ensure fair competition and compliance with antitrust laws.
$400.0M
Attorney General Tong led a coalition of 43 states and territories in announcing a $400 million settlement in principle with Sandoz Inc. to resolve allegations that the generic drug manufacturer engaged in conspiracies to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade. Sandoz will pay approximately $469 million total and implement internal reforms to ensure fair competition and compliance with antitrust laws.
$400.0M
The FTC, along with Utah and California, filed a complaint against Hims & Hers alleging the telehealth provider shared consumers' sensitive health information with third-party advertising platforms without consent, and deceived consumers about billing and cancellation practices. The complaint alleges violations of the FTC Act and the Restore Online Shoppers' Confidence Act.
The Minnesota Attorney General is holding a community forum to gather public input on the proposed acquisition of Allina Health by Sutter Health. The review is conducted under Minnesota's health care transaction law, charities law, and antitrust law to determine if the transaction is in the public interest. No enforcement action has been taken; this is a public consultation.
The FTC finalized a settlement with Vanilla Chip LLC (doing business as TruHeight) and its principals over allegations that they deceptively advertised height-enhancing supplements for children and teenagers without competent and reliable scientific evidence. The FTC also alleged that TruHeight used fake social media bot profiles and relied on reviews written by employees, vendors, or consumers who received free products or discounts for 5-star reviews. Under the final order, TruHeight must pay $750,000 and is barred from making unsupported health claims or misrepresenting reviews.
$750K
Attorney General Phil Weiser joined a bipartisan coalition of 48 states and territories in announcing a $29.6 million settlement with Glenmark Pharmaceuticals. The settlement resolves allegations that Glenmark participated in a widespread conspiracy to inflate prices, reduce competition, and restrain trade for numerous generic prescription drugs. Glenmark also agreed to cooperate in ongoing multistate litigation and implement internal reforms.
$29.6M
Minnesota Attorney General Keith Ellison reached a settlement with Annelle Soberay and Omega Dental Care, a defunct dental clinic that shut down in late 2024 without providing advance notice or transitional care to patients. The settlement allows consumers to obtain refunds from the Consumer Protection Restitution Account for fees paid for services that were never provided.
The New Jersey State Board of Pharmacy temporarily suspended the license of pharmacist Nittal K. Lodha and the permit of Woodbury Family Pharmacy for allegedly practicing unsafely, maintaining unsanitary conditions, and interfering with patients' rights to transfer prescriptions to other pharmacies. The suspension was ratified on June 24, 2026.
The FTC, along with Alaska, Iowa, Nebraska, and Texas, filed a lawsuit against WPATH alleging the organization made false and unsubstantiated claims about the necessity, safety, and effectiveness of pediatric medical transition services. The complaint alleges WPATH misled parents and children about medical consensus and failed to disclose serious side effects, in violation of the FTC Act.
The Minnesota Attorney General's Office is holding a community forum to gather public input on the proposed acquisition of Allina Health by Sutter Health. The review will assess compliance with state health care transaction law, charities law, and antitrust law to determine if the transaction is in the public interest.
Attorney General Ellison announced a $4.87 million multistate settlement with GS Labs for overcharging patients, charging unlawful administrative fees, and failing to deliver timely COVID-19 test results. The settlement includes $3.63 million in restitution to affected consumers and $1.25 million to the multistate group, along with injunctive relief if GS Labs resumes operations.
Colorado Attorney General Phil Weiser and a bipartisan coalition of 18 attorneys general announced a $4.87 million settlement with GS Labs, a former COVID-19 rapid testing business. The company was found to have violated the Colorado Consumer Protection Act by falsely advertising test results with no wait times, same day appointments, and no out-of-pocket expenses, while overcharging consumers and insurance providers.
$4.9M
The FTC sued Amare Global Holdings Inc. and its principals for falsely claiming that dietary supplements like Kids Happy Juice and Kids Mood+ could treat or cure depression, anxiety, and ADHD in children and adults. The FTC also alleged the company misled recruits about their potential earnings as 'brand partners' in its multilevel marketing scheme.
Texas Attorney General Ken Paxton announced the effective date of a $7.4 billion settlement with Purdue Pharma, Inc. and the Sackler family over their role in fueling the opioid crisis. Texas will receive $286.5 million from the settlement, bringing the state’s total opioid recovery funds to over $3 billion. The settlement includes permanent bans on Sackler opioid sales in the U.S., public release of 30 million company documents, and distribution of funds for addiction treatment and prevention over 15 years.
$7.4B
Connecticut Attorney General William Tong announced that Purdue Pharma will dissolve as the company’s bankruptcy concludes and a $7.4 billion settlement with Purdue and the Sackler family takes effect. The settlement permanently bars the Sacklers from selling opioids in the U.S., directs funds to addiction treatment and prevention, and requires the release of over 30 million documents related to Purdue’s opioid business. Connecticut is expected to receive $64 million from the settlement, with first payments anticipated in fall 2026.
$7.4B
New York Attorney General Letitia James announced the shutdown of opioid manufacturer Purdue Pharma as part of a $7.4 billion settlement with a bipartisan coalition of 54 other state attorneys general. The Sackler family, former owners of Purdue, are permanently barred from selling opioids in the U.S. and have no involvement in Knoa Pharma, the new public benefit corporation replacing Purdue. Purdue was sentenced on criminal charges related to its role in the opioid crisis on April 28, 2026, with the new entity operating under strict oversight and excess revenue funding opioid abatement efforts.
$7.4B
Virginia Attorney General Jay Jones joined a bipartisan coalition of 44 state attorneys general in submitting a comment letter supporting a proposed U.S. Department of Labor rule to increase transparency requirements for pharmacy benefit managers (PBMs) servicing employer-funded ERISA health plans. The coalition urged the DOL to clarify that the proposed rule does not preempt existing state PBM transparency laws and to coordinate enforcement with state attorneys general. This action is a policy advocacy comment letter and does not constitute an enforcement action against any specific entity.
The FTC alleged that Vanilla Chip LLC (d/b/a TruHeight) deceptively advertised height-enhancing supplements for children and teens without competent scientific evidence, and used fake employee-written and incentivized 5-star reviews. The proposed settlement requires TruHeight and its principals to pay $750,000, bars false health claims, and prohibits misleading review practices. A $4 million total judgment is partially suspended due to the respondents' inability to pay the full amount.
$750K
All data sourced from official government enforcement pages.